Advertisement
Screener

Skye Bioscience, Inc. (SKYE) Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals

1.5 / 5 stars · 13/42 Roast Me

Skye Bioscience, Inc. Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals

Skye Bioscience, Inc. (SKYE) had Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals of -$638.75 thousand as of 2015-12-31, per its 10-K filed 2017-03-10.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Liabilities

us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals · last filed 2017-03-10

  • 2015-12-31: Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals -$638.75K.
Period endDeferred Tax Liabilities, Deferred Expense, Reserves and Accruals
2015-12-31-$638.75K
10-K · filed 2017-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99